Third- and fourth-generation fluoroquinolones: Retrospective comparison of endophthalmitis after cataract surgery performed over 10 years

Journal of Cataract and Refractive Surgery

Volumn 34, Issue 9, 2008, Pages 1460-1467

  Jensen, Michael K ^a   Fiscella, Richard G ^a   Moshirfar, Majid ^a   Mooney, Barbara ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; MOXIFLOXACIN; OFLOXACIN;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; FEMALE; HUMAN; INFECTION RISK; MALE; PHACOEMULSIFICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; AZA COMPOUNDS; CIPROFLOXACIN; CROSS-SECTIONAL STUDIES; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; OFLOXACIN; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; PREVALENCE; QUINOLINES; RETROSPECTIVE STUDIES;

EID: 49649102957     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2008.05.045     Document Type: Article

References (28)

1. Powe N.R., Schein O.D., Gieser S.C., Tielsch J.M., Luthra R., Javitt J., and Steinberg E.P. Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation; the Cataract Patient Outcome Research Team. Arch Ophthalmol 112 (1994) 239-252 erratum, 889
2. Jensen M.K., Fiscella R.G., Crandall A.S., Moshifar M., Mooney B., Wallin T., and Olson R.J. A retrospective study of endophthalmitis rates comparing quinolone antibiotics. Am J Ophthalmol 139 (2005) 141-148
3. West E.S., Behrens A., McDonnell P.J., Tielsch J.M., and Schein O.D. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology 112 (2005) 1388-1394
4. Taban M., Behrens A., Newcomb R.L., Nobe M.Y., Saedi G., Sweet P.M., and McDonnell P.J. Acute endophthalmitis following cataract surgery; a systematic review of the literature. Arch Ophthalmol 123 (2005) 613-620
5. Jensen M.K., Fiscella R.G., and Lewis C.C. Using an infection-reporting database to improve outcomes in cataract-surgery patients. Am J Health Syst Pharm 61 (2004) 198-201
6. Taban M., Rao B., Reznik J., Zhang J., Chen Z., and McDonnell P.J. Dynamic morphology of sutureless cataract wounds-effect of incision angle and location. Surv Ophthalmol 49 suppl 2 (2004) S62-S72
7. Ciulla T.A., Starr M.B., and Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery. Ophthalmology 109 (2002) 13-26
8. Ta C.N. Topical antibiotic prophylaxis in intraocular injections. Arch Ophthalmol 125 (2007) 972-974
9. Deramo V.A., Lai J.C., Fastenberg D.M., and Udell I.J. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. Am J Ophthalmol 142 (2006) 721-725
10. Starr M.B. A retrospective study of endophthalmitis rates comparing quinolone antibiotics. [letter]. Am J Ophthalmol 140 (2005) 769-770
11. Thoms S.S., Musch D.C., and Soong H.K. Postoperative endophthalmitis associated with sutured versus unsutured clear corneal cataract incisions. Br J Ophthalmol 91 (2007) 728-730
12. Lai W.W., Chu K.O., Chan K.P., Choy K.W., Wang C.C., Tsang C.W., and Pang C.P. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy. Am J Ophthalmol 144 (2007) 315-318
13. Hwang D.G. Fluoroquinolone resistance in ophthalmology and the potential roles for newer ophthalmic fluoroquinolones. Surv Ophthalmol 49 suppl 2 (2004) S79-S83
14. Smith A., Pennefather P.M., Kaye S.B., and Hart C.A. Fluoroquinolones: place in ocular therapy. Drugs 61 (2001) 747-761
15. Kowalski R., Khaliwal D., Karenchak L., Romanowski E.G., Mah F.S., Ritterband D.C., and Gordon Y.J. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 136 (2003) 500-505
16. Mather R., Karenchak L.M., Romanowski E.G., and Kowalski R.P. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 133 (2002) 463-466
17. Mah F.S. New antibiotics for bacterial infections. Ophthalmol Clin North Am 16 1 (2003) 11-27
18. ESCRS Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33 (2007) 978-988
19. O'Brien T.P., Arshinoff S.A., and Mah F.S. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. J Cataract Refract Surg 33 (2007) 1790-1800
20. Kunimoto D.Y., Sharma S., Garg P., and Rao G.N. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin; emerging resistance. Ophthalmology 106 (1999) 80-85
21. Goldstein M.H., Kowalski R.P., and Gordon Y.J. Emerging fluoroquinolone resistance in bacterial keratitis; a 5-year review. Ophthalmology 106 (1999) 1313-1318
22. Garg P., Sharma S., and Rao G.N. Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology 106 (1999) 1319-1323
23. Chaudhry N.A., Flynn Jr. H.W., Murray T.G., Tabandeh H., Mello Jr. M.O., and Miller D. Emerging ciprofloxacin-resistant Pseudomonas aeruginosa. Am J Ophthalmol 128 (1999) 509-510
24. Bower K.S., Kowalski R.P., and Gordon Y.J. Fluoroquinolones in the treatment of bacterial keratitis. Am J Ophthalmol 121 (1996) 712-715
25. Alexandrakis G., Alfonso E.C., and Miller D. Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones. Ophthalmology 107 (2000) 1497-1502
26. Marangon F.B., Miller D., Muallem M.S., Romano A.C., and Alfonso E.C. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am J Ophthalmol 137 (2004) 453-458
27. Scheld W.M. Maintaining fluoroquinolone class efficacy: review of influencing factors. [editorial]. Emerg Infect Dis 9 (2003) 1-9. http://www.cdc.gov/ncidod/eid/vol9no1/02-0277.htm Accessed June 12, 2008
28. Kowalski R.P., and Dhaliwal D. Ocular bacterial infections: current and future treatment options. Expert Rev Anti Infect Ther 3 (2005) 131-139